Bioventus (BVS) Income from Continuing Operations (2020 - 2026)
Bioventus posted quarterly Income from Continuing Operations of 3946000.0 for Q1 2026, up 218.78% year-on-year from 1237829.27 in Q1 2025, and down 77.21% on a QoQ basis from 17318000.0 in Q4 2025.
Bioventus (BVS) has 7 years of Income from Continuing Operations data on file, last reported at 3946000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 218.78% year-over-year to 3946000.0; the trailing twelve-month figure through Mar 2026 stood at 34542000.0 (up 178.52% YoY), and the FY2025 full-year result was 27274000.0, up 157.97% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3946000.0, down from 17318000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 17318000.0 in Q4 2025 and bottomed at 101035000.0 in Q4 2022.
- The 5-year median for Income from Continuing Operations is 6381000.0 (2024), against an average of 16569176.47.
- The widest annual swing landed in 2022, when Income from Continuing Operations sank 85808.0%; it then surged 2971.97% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 21477000.0 in 2022, then jumped by 64.35% to 7656000.0 in 2023, then surged by 92.12% to 603000.0 in 2024, then soared by 2971.97% to 17318000.0 in 2025, then plunged by 77.21% to 3946000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3946000.0 (Q1 2026), 17318000.0 (Q4 2025), and 4006000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | 3.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 3.95 Mn |
| Dec 31, 2025 | 17.32 Mn |
| Sep 27, 2025 | 4.01 Mn |
| Jun 28, 2025 | 9.27 Mn |
| Mar 29, 2025 | -3.32 Mn |
| Dec 31, 2024 | -603,000.00 |
| Sep 28, 2024 | -5.85 Mn |
| Jun 29, 2024 | -34.22 Mn |
| Mar 30, 2024 | -6.38 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -8.79 Mn |
| Jul 1, 2023 | -4.73 Mn |
| Apr 1, 2023 | -100.02 Mn |
| Dec 31, 2022 | -21.48 Mn |
| Oct 1, 2022 | -101.04 Mn |
| Jul 2, 2022 | -7.73 Mn |
| Apr 2, 2022 | -14.41 Mn |
| Dec 31, 2021 | -25,000.00 |
| Oct 2, 2021 | -2.27 Mn |
| Jul 3, 2021 | -10.78 Mn |
| Apr 3, 2021 | 24.53 Mn |
| Dec 31, 2020 | 2.25 Mn |
| Sep 26, 2020 | 7.97 Mn |
| Jun 27, 2020 | -5.98 Mn |
| Mar 28, 2020 | 10.49 Mn |